pioglitazone has been researched along with Hashimoto Disease in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Hashimoto Disease: Chronic autoimmune thyroiditis, characterized by the presence of high serum thyroid AUTOANTIBODIES; GOITER; and HYPOTHYROIDISM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, B | 1 |
| Zheng, T | 1 |
| Dong, L | 1 |
| Mao, C | 1 |
| Xu, C | 1 |
| Mou, X | 1 |
| Luo, X | 1 |
| Lu, Q | 1 |
| Dong, X | 1 |
| Liu, J | 1 |
| Kang, P | 1 |
| Ding, C | 1 |
| Xiao, Y | 1 |
| Jiang, P | 1 |
| Werion, A | 1 |
| Joris, V | 1 |
| Hepp, M | 1 |
| Papasokrati, L | 1 |
| Marique, L | 1 |
| de Ville de Goyet, C | 1 |
| Van Regemorter, V | 1 |
| Mourad, M | 1 |
| Lengelé, B | 1 |
| Daumerie, C | 1 |
| Marbaix, E | 1 |
| Brichard, S | 1 |
| Many, MC | 1 |
| Craps, J | 1 |
2 other studies available for pioglitazone and Hashimoto Disease
| Article | Year |
|---|---|
Caveolin-1 Regulates CCL5 and PPARγ Expression in Nthy-ori 3-1 Cells: Possible Involvement of Caveolin-1 and CCL5 in the Pathogenesis of Hashimoto's Thyroiditis.
Topics: Caveolin 1; Cell Line; Cell Movement; Chemokine CCL5; Gene Expression; Hashimoto Disease; Humans; Pi | 2020 |
Pioglitazone, a PPARγ Agonist, Upregulates the Expression of Caveolin-1 and Catalase, Essential for Thyroid Cell Homeostasis: A Clue to the Pathogenesis of Hashimoto's Thyroiditis.
Topics: Autoantigens; Catalase; Caveolin 1; Cells, Cultured; Dual Oxidases; Hashimoto Disease; Humans; Hypog | 2016 |